HomeAgenda

ServiceUpdated on 1 October 2025

R&D Preclinical Services in Hearing Disorders (Small Molecule to gene) or Joint Research Agreement

About

Cilcare advances hearing disorder R&D with preclinical services (GLP tox, in vivo studies) and serves as an external innovation platform for product development, joint research, and partnerships — covering small molecules to gene therapies.

Type

  • Development
  • Consulting

Applies to

  • Biotech and Lifescience

Organisation

Cilcare

Company (SME/startup) / 中小企業・スタートアップ

Montpellier, France